8:16am PDT - June 5th, 2023

RT @tompowles1: The THOR study: erdafitinib vs chemo in pretreated advanced FGFR+ve UC=OS benefit (HR=0.64,RR 45%). Sfx different from chem…

0 retweets   36 likes  - Roger Li (@UrogerliMD)